New Stock News | Youli Sai Hong Kong Stock IPO Prospectus Invalid
Suzhou Youlesai Shared Service Co., Ltd. (referred to as Youlesai), whose Hong Kong stock prospectus was submitted on June 13 and expired after 6 months on December 13, with Citic Securities International as its exclusive sponsor at the time of submission.
Suzhou Youlesai Shared Services Co., Ltd. (referred to as Youlesai) submitted its Hong Kong IPO prospectus on June 13, which expired after 6 months on December 13, with China Securities Co., Ltd. International as its exclusive sponsor.
According to the prospectus, Youlesai is a Chinese provider of circular packaging services, primarily focusing on providing services to automotive parts manufacturers and OEMs within the automotive industry. Youlesai offers shared operation services, leasing services, and other value-added services for circular containers to customers who need efficient and sustainable solutions to manage supply chain logistics. Additionally, Youlesai also sells containers to customers who use containers in their own facilities or have the capability to independently manage container operations. According to Frost & Sullivan, by 2024 revenue, Youlesai is the second largest provider of circular packaging services in China and the largest provider in China's automotive shared operation services market. In 2024, circular packaging services, shared operation services, and automotive shared operation services accounted for 6.4%, 2.4%, and 1.0% of the overall logistics packaging solutions market in China, respectively.
Related Articles

BOSS ZHIPIN-W(02076) awarded a total of 345,900 shares as rewards.

China Securities Co., Ltd.: Can the structural market turn fully bullish? Key factors include funds, valuations, and risk premiums in three major dimensions.

GENSCRIPT BIO (01548) awarded a total of 36,300 shares as a reward.
BOSS ZHIPIN-W(02076) awarded a total of 345,900 shares as rewards.

China Securities Co., Ltd.: Can the structural market turn fully bullish? Key factors include funds, valuations, and risk premiums in three major dimensions.

GENSCRIPT BIO (01548) awarded a total of 36,300 shares as a reward.

RECOMMEND

Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025

Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025

Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025


